All posts tagged: Digest

Assorted news from the last week: The STAR Act was crafted by parents, doctors, and organizations who strive to make a difference for children with cancer and their families, in partnership with legislators and others.  CAC2 Member Danielle Leach explains its importance in this CDC blog post. Adding temozolomide to a combination of vincristine and irinotecan (VIT) improved tumor response and survival in patients with relapsed or refractory rhabdomyosarcoma in a European phase II trial. In some children with acute myeloid leukemia, cancer cells have the same amount of DNA changes as healthy blood stem cells. Researchers were surprised to […]

Assorted news from the last week: New York Times op-ed piece by CNN investigative reporter Andrew Kaczynski on the financial toxicity of a childhood cancer diagnosis (gated). Scientists at St. Jude Children’s Research Hospital have created a laboratory model for studying retinoblastoma driven by inherited mutations in the RB1 gene. Adam Haydn argues that scientists need a better way to follow and learn from long-term survivors. New NCI task force focuses on quality of life for AYAs with cancer. Upcoming Webinars and Online Opportunities: Video links available for the public sessions of the 2021 CAC2 Annual Summit. Pediatric nurse practitioners […]